相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis
Sahajal Dhooria et al.
CHEST (2022)
Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival
Patricia Caetano Mota et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2022)
Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment
Martina Sterclova et al.
BIOMEDICAL REPORTS (2021)
Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF
Francesco Bonella et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
Paolo Spagnolo et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Davide Biondini et al.
RESPIRATORY RESEARCH (2021)
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?
Carmel J. Stock et al.
THORAX (2020)
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology
Elisabetta Cocconcelli et al.
JOURNAL OF CLINICAL MEDICINE (2019)
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment
Lisabetta Balestro et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort
Hui Wang et al.
SCIENTIFIC REPORTS (2019)
Localization of Secretory Mucins MUC5AC and MUC5B in Normal/Healthy Human Airways
Kenichi Okuda et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis
Chad A. Newton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease
Ayodeji Adegunsoye et al.
CHEST (2019)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
Davide Biondini et al.
SCIENTIFIC REPORTS (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways
David A. Schwartz
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease
A. Livraghi-Butrico et al.
MUCOSAL IMMUNOLOGY (2017)
CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism
Jonathan H. Chung et al.
CHEST (2016)
The MUC5B Promoter Polymorphism Is Associated With Idiopathic Pulmonary Fibrosis in a Mexican Cohort but Is Rare Among Asian Ancestries
Anna L. Peljto et al.
CHEST (2015)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
Anna L. Peljto et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population
Raphael Borie et al.
PLOS ONE (2013)
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis
Carmel J. Stock et al.
THORAX (2013)
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
Imre Noth et al.
LANCET RESPIRATORY MEDICINE (2013)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Idiopathic Pulmonary Fibrosis - A Sticky Business
Richard C. Boucher
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Max A. Seibold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Predictors of a Diagnosis of Idiopathic Pulmonary Fibrosis
Charlene D. Fell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
High-resolution computed tomography in idiopathic pulmonary fibrosis: Diagnosis and prognosis
DA Lynch et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
分享论文
